Cano Health Inc (CANO)

Ticker: CANO Exchange: NYS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cano Health Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
23.93
Quantity 97,811 -14.0%
Value US$3,511,082
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
49.41
Quantity 20,913 -26.2%
Value US$2,147,121
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
328.31
Quantity 62,139 -38.5%
Value US$67,353
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.74
Quantity 41,357 -7.1%
Value US$113,471
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.74
Quantity 32,693 -5.3%
Value US$89,736
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.58
Quantity 18,569 -2.9%
Value US$47,960
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.84
Quantity 35,808 -5.4%
Value US$101,612
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.94
Quantity 73,034 -9.9%
Value US$214,800
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.50
Quantity 125,000 -14.4%
Value US$312,762
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
1.91
Quantity 100,000 -10.4%
Value US$191,250
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.92
Quantity 5,987 -0.6%
Value US$17,489
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.28
Quantity 94,013 -8.8%
Value US$214,058
ITC Rumba, LLC 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
3.00
Quantity 720,876
Value US$2,162,000
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.30
Quantity 24,171 -100.0%
Value US$79,878
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.59
Quantity 25,000 -50.8%
Value US$89,790
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.73
Quantity 25,000 -33.7%
Value US$93,292
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.75
Quantity 25,000 -25.2%
Value US$93,672
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.82
Quantity 25,000 -20.1%
Value US$95,552
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.85
Quantity 25,000 -16.8%
Value US$96,232
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
4.00
Quantity 13,328 -8.2%
Value US$53,297
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
4.94
Quantity 24,182 -13.0%
Value US$119,423
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
4.08
Quantity 50,818 -21.4%
Value US$207,251
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
5.42
Quantity 43,505 -15.5%
Value US$235,658
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
6.00
Quantity 35,112 -11.1%
Value US$210,644
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
6.00
Quantity 41,197 -11.5%
Value US$247,227
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
5.65
Quantity 37,607 -9.5%
Value US$212,370
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
5.44
Quantity 21,154 -5.1%
Value US$115,124
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
5.65
Quantity 27,377 -6.2%
Value US$154,787
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
6.62
Quantity 6,309 -1.4%
Value US$41,765
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
5.67
Quantity 82,843 -15.6%
Value US$469,430
ITC Rumba, LLC 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
11.08
Quantity 532,603
Value US$5,902,000
3.2
Barry S. Sternlicht Affiliate
Transaction date
Proposed sale
Price
12.05
Quantity 176,211
Value US$2,123,343
3.4
Camerlinck Robert Chief Operating Officer Officer
Transaction date
Sale
Price
0.77
Quantity 30,646 -0.1%
Value US$23,453
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.31
Quantity 400,000
Value US$525,745
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.22
Quantity 150,000
Value US$183,300
Aguilar Richard Chief Clinical Officer Officer
Transaction date
Sale
Price
1.42
Quantity 500,000 -29.2%
Value US$711,650
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.42
Quantity 500,000
Value US$711,650
Aguilar Richard Chief Clinical Officer Officer
Transaction date
Sale
Price
1.38
Quantity 100,000 -5.5%
Value US$137,760
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.38
Quantity 100,000
Value US$137,760
Aguilar Richard Chief Clinical Officer Officer
Transaction date
Sale
Price
1.29
Quantity 275,940 -13.2%
Value US$356,156
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.29
Quantity 275,940
Value US$355,963
Aguilar Richard Chief Clinical Officer Officer
Transaction date
Sale
Price
1.32
Quantity 400,000 -21.2%
Value US$528,400
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.32
Quantity 400,000
Value US$528,400
3.1
Armstrong David J See remarks Officer
Transaction date
Sale
Price
1.38
Quantity 3,163 -0.5%
Value US$4,351
1.7
Koppy Brian D Chief Financial Officer Officer
Transaction date
Sale
Price
1.27
Quantity 23,591 -2.9%
Value US$30,067
0.6
Gold Lewis Non-Executive Director
Transaction date
Purchase
Price
6.81
Quantity 300,000 +2023.6%
Value US$2,043,000
1.9
Hernandez Marlow CEO and President Executive Director
Transaction date
Purchase
Price
8.00
Quantity 15,000 +0.5%
Value US$120,000
1.9
Hernandez Marlow CEO and President Executive Director
Transaction date
Purchase
Price
8.75
Quantity 12,500 +0.4%
Value US$109,375
1.9
Hernandez Marlow CEO and President Executive Director
Transaction date
Purchase
Price
9.65
Quantity 8,000 +0.3%
Value US$77,200
0.6
TRUJILLO SOLOMON D Non-Executive Director
Transaction date
Purchase
Price
10.55
Quantity 97,000 +inf%
Value US$1,023,350
1.9
Hernandez Marlow CEO and President Executive Director
Transaction date
Purchase
Price
11.99
Quantity 2,500 +3.8%
Value US$29,975
1.9
Hernandez Marlow CEO and President Executive Director
Transaction date
Purchase
Price
11.99
Quantity 5,833 +0.4%
Value US$69,938
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-02 2024-02-01 S Sale Large shareholder
97,811 -14.0%
23.93
US$3,511,082
97,811 -14.0% 23.93 US$3,511,082
2024-02-02 2024-01-31 S Sale Large shareholder
20,913 -26.2%
49.41
US$2,147,121
20,913 -26.2% 49.41 US$2,147,121
2024-02-02 2024-01-30 S Sale Large shareholder
62,139 -38.5%
328.31
US$67,353
62,139 -38.5% 328.31 US$67,353
2024-01-29 2024-01-29 S Sale Large shareholder
41,357 -7.1%
2.74
US$113,471
41,357 -7.1% 2.74 US$113,471
2024-01-29 2024-01-26 S Sale Large shareholder
32,693 -5.3%
2.74
US$89,736
32,693 -5.3% 2.74 US$89,736
2024-01-29 2024-01-25 S Sale Large shareholder
18,569 -2.9%
2.58
US$47,960
18,569 -2.9% 2.58 US$47,960
2024-01-24 2024-01-24 S Sale Large shareholder
35,808 -5.4%
2.84
US$101,612
35,808 -5.4% 2.84 US$101,612
2024-01-24 2024-01-23 S Sale Large shareholder
73,034 -9.9%
2.94
US$214,800
73,034 -9.9% 2.94 US$214,800
2024-01-24 2024-01-22 S Sale Large shareholder
125,000 -14.4%
2.50
US$312,762
125,000 -14.4% 2.50 US$312,762
2024-01-19 2024-01-18 S Sale Large shareholder
100,000 -10.4%
1.91
US$191,250
100,000 -10.4% 1.91 US$191,250
2024-01-19 2024-01-17 S Sale Large shareholder
5,987 -0.6%
2.92
US$17,489
5,987 -0.6% 2.92 US$17,489
2024-01-19 2024-01-17 S Sale Large shareholder
94,013 -8.8%
2.28
US$214,058
94,013 -8.8% 2.28 US$214,058
2024-01-17 2024-01-17 PrS Proposed sale

10% Stockholder

Large shareholder
720,876
3.00
US$2,162,000
720,876 3.00 US$2,162,000
2024-01-12 2024-01-12 S Sale Large shareholder
24,171 -100.0%
3.30
US$79,878
24,171 -100.0% 3.30 US$79,878
2024-01-12 2024-01-11 S Sale Large shareholder
25,000 -50.8%
3.59
US$89,790
25,000 -50.8% 3.59 US$89,790
2024-01-12 2024-01-10 S Sale Large shareholder
25,000 -33.7%
3.73
US$93,292
25,000 -33.7% 3.73 US$93,292
2024-01-09 2024-01-09 S Sale Large shareholder
25,000 -25.2%
3.75
US$93,672
25,000 -25.2% 3.75 US$93,672
2024-01-09 2024-01-08 S Sale Large shareholder
25,000 -20.1%
3.82
US$95,552
25,000 -20.1% 3.82 US$95,552
2024-01-09 2024-01-05 S Sale Large shareholder
25,000 -16.8%
3.85
US$96,232
25,000 -16.8% 3.85 US$96,232
2024-01-04 2024-01-04 S Sale Large shareholder
13,328 -8.2%
4.00
US$53,297
13,328 -8.2% 4.00 US$53,297
2024-01-04 2024-01-03 S Sale Large shareholder
24,182 -13.0%
4.94
US$119,423
24,182 -13.0% 4.94 US$119,423
2024-01-04 2024-01-03 S Sale Large shareholder
50,818 -21.4%
4.08
US$207,251
50,818 -21.4% 4.08 US$207,251
2024-01-04 2024-01-02 S Sale Large shareholder
43,505 -15.5%
5.42
US$235,658
43,505 -15.5% 5.42 US$235,658
2023-12-29 2023-12-29 S Sale Large shareholder
35,112 -11.1%
6.00
US$210,644
35,112 -11.1% 6.00 US$210,644
2023-12-29 2023-12-28 S Sale Large shareholder
41,197 -11.5%
6.00
US$247,227
41,197 -11.5% 6.00 US$247,227
2023-12-29 2023-12-27 S Sale Large shareholder
37,607 -9.5%
5.65
US$212,370
37,607 -9.5% 5.65 US$212,370
2023-12-26 2023-12-26 S Sale Large shareholder
21,154 -5.1%
5.44
US$115,124
21,154 -5.1% 5.44 US$115,124
2023-12-26 2023-12-22 S Sale Large shareholder
27,377 -6.2%
5.65
US$154,787
27,377 -6.2% 5.65 US$154,787
2023-12-26 2023-12-21 S Sale Large shareholder
6,309 -1.4%
6.62
US$41,765
6,309 -1.4% 6.62 US$41,765
2023-12-26 2023-12-21 S Sale Large shareholder
82,843 -15.6%
5.67
US$469,430
82,843 -15.6% 5.67 US$469,430
2023-12-21 2023-12-21 PrS Proposed sale

10% Stockholder

Large shareholder
532,603
11.08
US$5,902,000
532,603 11.08 US$5,902,000
2023-12-07 2023-12-07 PrS Proposed sale

Affiliate

176,211
12.05
US$2,123,343
176,211 12.05 US$2,123,343
2023-08-15 2023-08-11 S Sale

Chief Operating Officer

Officer
30,646 -0.1%
0.77
US$23,453
30,646 -0.1% 0.77 US$23,453
2023-06-29 2023-06-29 PrS Proposed sale

Director

Non-Executive Director
400,000
1.31
US$525,745
400,000 1.31 US$525,745
2023-06-28 2023-06-28 PrS Proposed sale

Director

Non-Executive Director
150,000
1.22
US$183,300
150,000 1.22 US$183,300
2023-06-13 2023-06-12 S Sale

Chief Clinical Officer

Officer
500,000 -29.2%
1.42
US$711,650
500,000 -29.2% 1.42 US$711,650
2023-06-12 2023-06-12 PrS Proposed sale

Director

Non-Executive Director
500,000
1.42
US$711,650
500,000 1.42 US$711,650
2023-06-13 2023-06-09 S Sale

Chief Clinical Officer

Officer
100,000 -5.5%
1.38
US$137,760
100,000 -5.5% 1.38 US$137,760
2023-06-09 2023-06-09 PrS Proposed sale

Director

Non-Executive Director
100,000
1.38
US$137,760
100,000 1.38 US$137,760
2023-06-13 2023-06-08 S Sale

Chief Clinical Officer

Officer
275,940 -13.2%
1.29
US$356,156
275,940 -13.2% 1.29 US$356,156
2023-06-08 2023-06-08 PrS Proposed sale

Director

Non-Executive Director
275,940
1.29
US$355,963
275,940 1.29 US$355,963
2023-06-13 2023-06-07 S Sale

Chief Clinical Officer

Officer
400,000 -21.2%
1.32
US$528,400
400,000 -21.2% 1.32 US$528,400
2023-06-07 2023-06-07 PrS Proposed sale

Director

Non-Executive Director
400,000
1.32
US$528,400
400,000 1.32 US$528,400
2023-06-07 2023-06-06 S Sale

See remarks

Officer
3,163 -0.5%
1.38
US$4,351
3,163 -0.5% 1.38 US$4,351
2023-04-07 2023-04-05 S Sale

Chief Financial Officer

Officer
23,591 -2.9%
1.27
US$30,067
23,591 -2.9% 1.27 US$30,067
2022-03-21 2022-03-17 B Purchase Non-Executive Director
300,000 +2023.6%
6.81
US$2,043,000
300,000 +2023.6% 6.81 US$2,043,000
2021-12-07 2021-12-06 B Purchase

CEO and President

Executive Director
15,000 +0.5%
8.00
US$120,000
15,000 +0.5% 8.00 US$120,000
2021-12-06 2021-12-03 B Purchase

CEO and President

Executive Director
12,500 +0.4%
8.75
US$109,375
12,500 +0.4% 8.75 US$109,375
2021-11-24 2021-11-22 B Purchase

CEO and President

Executive Director
8,000 +0.3%
9.65
US$77,200
8,000 +0.3% 9.65 US$77,200
2021-11-30 2021-11-18 B Purchase Non-Executive Director
97,000 +inf%
10.55
US$1,023,350
97,000 +inf% 10.55 US$1,023,350
2021-09-02 2021-08-31 B Purchase

CEO and President

Executive Director
2,500 +3.8%
11.99
US$29,975
2,500 +3.8% 11.99 US$29,975
2021-09-02 2021-08-31 B Purchase

CEO and President

Executive Director
5,833 +0.4%
11.99
US$69,938
5,833 +0.4% 11.99 US$69,938